Major Depressive Disorder
5 competing products in clinical development for Major Depressive Disorder.
Pipeline by Phase
Pre-clinical1
Phase 11
Phase 21
Phase 32
All Products (5)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Duloxetine | Eli Lilly | Phase 3 | Completed | 77 |
| Duloxetine + Paroxetine | Eli Lilly | Phase 3 | Completed | 77 |
| LY2216684 + Placebo + Escitalopram | Eli Lilly | Phase 2 | Completed | 52 |
| LY2216684 + Digoxin | Eli Lilly | Phase 1 | Completed | 33 |
| Duloxetine Hydrochloride | Eli Lilly | Pre-clinical | Completed | 23 |